Key takeaways Mounjaro is approved for Type 2 diabetes but is often used off-label for weight loss due to its appetite-suppressing effects
Diabetes 62:424434 Colvin GB, Whitmoyer DI, Sawyer CH (1969) Circadian sleep-wakefulness patterns in rats after ovariectomy and treatment with estrogen
There were some obvious signs that these are not entirely aboveboard operations, though
E., Metro, D., Alibrandi, A., Papa, M
To summarize the last article: GLP-1 medications are reshaping modern medicine because they target the gut-brain-metabolic axis that drives most chronic disease - not just weight loss, but cardiovascular disease, heart failure, kidney disease, neurodegeneration, fatty liver, and systemic inflammation